NEO Operating Cash Flow (Statement)
Neogenomics Inc · Operating Cash Flow (Statement)
NEO Operating Cash Flow (Statement)
Latest reported$22.05Mperiod ending
NEO Cash from Operations (-$177.13K → $22.05M)
Annual operating cash flow (statement)
High-resolution chart · PNG
NEO operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 5,230,000 | |
| 7,023,000 | |
| -1,953,000 | |
| -65,993,000 | |
| -26,723,000 | |
| 1,460,000 | |
| 23,369,000 | |
| 44,786,000 | |
| 18,037,000 | |
| 21,477,000 | |
| 6,393,000 | |
| 9,450,000 | |
| 2,227,000 | |
| -492,000 | |
| 69,000 | |
| -2,052,000 | |
| -1,500,417 | |
| -138,306 | |
| -2,642,591 | |
| -693,782 | |
| -902,051 | |
| -658,133 | |
| -532,366 | |
| -384,796 | |
| -77,407 | |
| -177,131 |